Freeman sets up US subsidiary and plans to establish service lab
Freeman Technology says growing Pharma demand for analytical data prompted the formation of US subsidiary and it behind its plans for a new laboratory.
Archives for February 22, 2012
update
BASF hikes EOA prices again
BASF has increased its European prices for ethanolamines (EOA) for the third time in as many months.
Warnex pulls out of analytical services divestiture
Warnex has pulled out of a C$1.1m (€833,000) deal to sell its analytical services business, alleging that the buyer failed to fulfil its obligations.
EXCLUSIVE
Bespak hunting development deals for nasal spray tech
Bespak is on the hunt for more development contracts for its new nasal delivery platform.
FDA allows temporary import of Sun’s Doxil alt to ease shortage
The US FDA is allowing Sun Pharma to import a version of Doxil to ease the drug shortage created by manufacturing failings at Ben Venue.
Frontage expands CMO consultancy offering in China
Frontage Laboratories says it is focussing on improving regulatory and GMP compliance in China after signing a $10m (€7.5m) collaboration with drugs maker Fanghui Pharma.
GDP guidelines would increase EU supply chain costs; industry
Draft EU GDP guidelines would “significantly increase” supply-chain costs and be “virtually impossible” to carry out, big pharma and logistics companies said.
CMO deals roundup – Jubilant, Boehringer, and Scynexis
Outsourcing-Pharma presents a round of new contract manufacturing deals, including business wins for Boehringer, Jubilant and Scynexis.